Table 2 Perceived COVID-19 Disruptions and Innovations Throughout Study Period
From: Impact of COVID-19 on HIV service delivery in Miami-Dade County: a mixed methods study
Service | Apr-Jul 2020 (N=15) | Jan-Feb 2021 (N=39) | Mar-Apr 2021 (N=24) | Jun-Sep 2021 (N=17) | Oct '21-Feb 2022 (N=11) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Disruption | Innovation | Disruption | Innovation | Disruption | Innovation | Disruption | Innovation | Disruption | Innovation | |
Antiretroviral Initiation | 20% | 20% | 15% | 33% | 12% | 21% | 12% | 18% | 18% | 64% |
Antiretroviral Lab Monitoring | 7% | 7% | 13% | 26% | 12% | 21% | 24% | 24% | 36% | 55% |
HIV Antibody Testing | 33% | 40% | 33% | 56% | 29% | 54% | 24% | 29% | 36% | 82% |
HIV Case Management | 27% | 33% | 23% | 46% | 29% | 46% | 12% | 24% | 27% | 64% |
Laboratory Monitoring for STI | 13% | 20% | 18% | 28% | 21% | 25% | 24% | 24% | 27% | 55% |
Mental and Psychosocial Health | 27% | 20% | 23% | 36% | 29% | 33% | 18% | 24% | 18% | 55% |
PEP Initiation | 20% | 27% | 23% | 33% | 21% | 29% | 12% | 12% | 27% | 45% |
PrEP Initiation | 20% | 27% | 26% | 49% | 25% | 33% | 12% | 18% | 27% | 64% |
Sexual / Reproductive Health | 27% | 27% | 21% | 36% | 17% | 38% | 12% | 18% | 18% | 55% |
STI Testing | 27% | 27% | 38% | 44% | 38% | 46% | 24% | 29% | 45% | 55% |
Substance Use | 27% | 20% | 23% | 28% | 25% | 33% | 18% | 24% | 18% | 55% |